Novel M3 muscarinic acetylcholine receptor antagonists

Details for Australian Patent Application No. 2004296208 (hide)

Owner Glaxo Group Limited

Inventors Busch-Petersen, Jakob; Jin, Jian; Shi, Dongchuan

Agent Davies Collison Cave

Pub. Number AU-A-2004296208

PCT Pub. Number WO2005/055941

Priority 60/526,766 03.12.03 US

Filing date 3 December 2004

Wipo publication date 23 June 2005

International Classifications

A61K 31/445 (2006.01) - Non-condensed piperidines, e.g. piperocaine

Event Publications

22 June 2006 PCT application entered the National Phase

  PCT publication WO2005/055941 Priority application(s): WO2005/055941

11 September 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004296213-Anti-diarrhea composition containing glutamine

2004296207-Novel M3 muscarinic acetylcholine receptor antagonists